Evidence map›Paper›PMID 17898059›Full record

ArticleJournal of virology2007

Identification of CD46 binding sites within the adenovirus serotype 35 fiber knob.

Hongjie Wang, Yen-Chywan Liaw, Daniel Stone, Oleksandr Kalyuzhniy, Imameddin Amiraslanov, Sebastian Tuve, Christophe L M J Verlinde, Dmitry Shayakhmetov, Thilo Stehle, Steve Roffler and 1 more

Abstract read
In one paragraph

Article in Journal of virology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Journal of virology · 2022
    Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hongjie WangDivision of Medical Genetics, University of Washington, Box 357720, Seattle, WA 98195, USA.
Yen-Chywan Liaw
Daniel Stone
Oleksandr Kalyuzhniy
Imameddin Amiraslanov
Sebastian Tuve
Christophe L M J Verlinde
Dmitry Shayakhmetov
Thilo Stehle
Steve Roffler
André Lieber

Funding

Innate immunity to adenovirus vectorsR01AI065429 · NIAID · UNIVERSITY OF WASHINGTON · PI SHAYAKHMETOV, DMITRY · 2005 to 2019
$5.6M
NIAID NIH HHS AI065429NIAID NIH HHS R01 AI065429PHS HHS HLA078836
6 · The paper itself

Abstract

Species B human adenoviruses (Ads) are often associated with fatal illnesses in immunocompromised individuals. Recently, species B Ads, most of which use the ubiquitously expressed complement regulatory protein CD46 as a primary attachment receptor, have gained interest for use as gene therapy vectors. In this study, we focused on species B Ad serotype 35 (Ad35), whose trimeric fiber knob domain binds to three CD46 molecules with a KD (equilibrium dissociation constant) of 15.5 nM. To study the Ad35 knob-CD46 interaction, we generated an expression library of Ad35 knobs with random mutations and screened it for CD46 binding. We identified four critical residues (Phe242, Arg279, Ser282, and Glu302) which, when mutated, ablated Ad35 knob binding to CD46 without affecting knob trimerization. The functional importance of the identified residues was validated in surface plasmon resonance and competition binding studies. To model the Ad35 knob-CD46 interaction, we resolved the Ad35 knob structure at 2-A resolution by X-ray crystallography and overlaid it onto the existing structure for Ad11-CD46 interaction. According to our model, all identified Ad35 residues are in regions that interact with CD46, whereby one CD46 molecule binds between two knob monomers. This mode of interaction might have potential consequences for CD46 signaling and intracellular trafficking of Ad35. Our findings are also fundamental for better characterization of species B Ads and design of antiviral drugs, as well as for application of species B Ads as in vivo and in vitro gene transfer vectors.

Indexed as

AdenoviridaeAmino Acid SubstitutionBinding SitesCapsid ProteinsCrystallography, X-RayDNA Mutational AnalysisHumansMembrane Cofactor ProteinModels, MolecularMutation, MissenseProtein BindingProtein Structure, TertiaryReceptors, VirusSurface Plasmon ResonanceCapsid Proteinshexon capsid protein, AdenovirusMembrane Cofactor ProteinReceptors, Virus

Identifiers

PMID17898059
PMCPMC2169084

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.